Constitutive activity of glycogen synthase kinase-3β: Positive regulation of steady-state levels of insulin receptor substrates-1 and -2 in adrenal chromaffin cells

Brain Research

Volumn 1110, Issue 1, 2006, Pages 1-12

  Nemoto, Takayuki ^a   Yokoo, Hiroki ^a   Satoh, Shinya ^a   Yanagita, Toshihiko ^a   Sugano, Takashi ^a   Yoshikawa, Norie ^a   Maruta, Toyoaki ^a   Kobayashi, Hideyuki ^a   Wada, Akihiko ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Catenin; Adrenal chromaffin cell; Constitutive up regulation of insulin receptor substrates 1 and 2; Glycogen synthase kinase 3 ; LiCl; Proteasome

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; BETA CATENIN; CALPASTATIN; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; LACTACYSTIN; LACTACYSTIN BETA LACTONE; LEUPEPTIN; LITHIUM CHLORIDE; MESSENGER RNA; PROTEASOME INHIBITOR; SERINE;

ANIMAL CELL; ARTICLE; CHROMAFFIN CELL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; COW; DOWN REGULATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; STEADY STATE;

ACETYLCYSTEINE; ADJUVANTS, IMMUNOLOGIC; ADRENAL GLANDS; ANIMALS; BLOTTING, NORTHERN; CATTLE; CELLS, CULTURED; CHROMAFFIN CELLS; CYSTEINE PROTEINASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; INDOLES; LACTONES; LITHIUM CHLORIDE; MALEIMIDES; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; SERINE; TIME FACTORS;

BOS TAURUS;

EID: 33748422468     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.06.053     Document Type: Article

References (55)

1. Akune T., Ogata N., Hoshi K., Kubota N., Terauchi Y., Tobe K., Takagi H., Azuma Y., Kadowaki T., Nakamura K., and Kawaguchi H. Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts. J. Cell Biol. 159 (2002) 147-156
2. Barbieri M., Bonafè M., Franceschi C., and Paolisso G. Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans. Am. J. Physiol.: Endocrinol. Metab. 285 (2003) E1064-E1071
3. Briaud I., Dickson L.M., Lingohr M.K., McCuaig J.F., Lawrence J.C., and Rhodes C.J. Insulin receptor substrate-2 proteasomal degradation mediated by a mammalian target of rapamycin (mTOR)-induced negative feedback down-regulates protein kinase B-mediated signaling pathway in β-cells. J. Biol. Chem. 280 (2005) 2282-2293
4. Brussee V., Cunningham F.A., and Zochodne D.W. Direct insulin signaling of neurons reverses diabetic neuropathy. Diabetes 53 (2004) 1824-1830
5. Carro E., and Torres-Aleman I. The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease. Eur. J. Pharmacol. 490 (2004) 127-133
6. Chen J., Wu A., Sun H., Drakas R., Garofalo C., Cascio S., Surmacz E., and Baserga R. Functional significance of type 1 insulin-like growth factor-mediated nuclear translocation of the insulin receptor substrate-1 and β-catenin. J. Biol. Chem. 280 (2005) 29912-29920
7. Coghlan M.P., Culbert A.A., Cross D.A.E., Corcoran S.L., Yates J.W., Pearce N.J., Rausch O.L., Murphy G.J., Carter P.S., Cox L.R., Mills D., Brown M.J., Haigh D., Ward R.W., Smith D.G., Murray K.J., Reith A.D., and Holder J.C. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem. Biol. 7 (2000) 793-803
8. Cross D.A.E., Culbert A.A., Chalmers K.A., Facci L., Skaper S.D., and Reith A.D. Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurons from death. J. Neurochem. 77 (2001) 94-102
9. De Sarno P., Li X., and Jope R.S. Regulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium. Neuropharmacology 43 (2002) 1158-1164
10. Eldar-Finkelman H., and Krebs E.G. Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 9660-9664
11. 1 integrins. J. Cell Biol. 166 (2004) 407-418
12. Gould T.D., Chen G., and Manji H.K. In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3. Neuropsychopharmacology 29 (2004) 32-38
13. Greene M.W., Sakaue H., Wang L., Alessi D.R., and Roth R.A. Modulation of insulin-stimulated degradation of human insulin receptor substrate-1 by serine 312 phosphorylation. J. Biol. Chem. 278 (2003) 8199-8211
14. Grimes C.A., and Jope R.S. CREB DNA binding activity is inhibited by glycogen synthase kinase-3β and facilitated by lithium. J. Neurochem. 78 (2001) 1219-1232
15. Gual P., Le Marchand-Brustel Y., and Tanti J.-F. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87 (2005) 99-109
16. Haruta T., Uno T., Kawahara J., Takano A., Egawa K., Sharma P.M., Olefsky J.M., and Kobayashi M. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. Mol. Endocrinol. 14 (2000) 783-794
17. Hegde A.N. Ubiquitin-proteasome-mediated local protein degradation and synaptic plasticity. Prog. Neurobiol. 73 (2004) 311-357
18. Hirashima Y., Tsuruzoe K., Kodama S., Igata M., Toyonaga T., Ueki K., Kahn C.R., and Araki E. Insulin down-regulates insulin receptor substrate-2 expression through the phosphatidylinositol 3-kinase/Akt pathway. J. Endocrinol. 179 (2003) 253-266
19. Hoeflich K.P., Luo J., Rubie E.A., Tsao M.-S., Jin O., and Woodgett J.R. Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation. Nature 406 (2000) 86-90
20. Jope R.S. Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol. Sci. 24 (2003) 441-443
21. Jope R.S., and Johnson G.V.W. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29 (2004) 95-102
22. Kim B., van Golen C.M., and Feldman E.L. Insulin-like growth factor I induces preferential degradation of insulin receptor substrate-2 through the phosphatidylinositol 3-kinase pathway in human neuroblastoma cells. Endocrinology 146 (2005) 5350-5357
23. Klein P.S., and Melton D.A. A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 8455-8459
24. Kubota T., Kubota N., Moroi M., Terauchi Y., Kobayashi T., Kamata K., Suzuki R., Tobe K., Namiki A., Aizawa S., Nagai R., Kadowaki T., and Yamaguchi T. Lack of insulin receptor substrate-2 causes progressive neointima formation in response to vessel injury. Circulation 107 (2003) 3073-3080
25. Lee D.H., and Goldberg A.L. Selective inhibitors of the proteasome-dependent and vacuolar pathways of protein degradation in Saccharomyces cerevisiae. J. Biol. Chem. 271 (1996) 27280-27284
26. Lee Y.-I., Seo M., Kim Y., Kim S.-Y., Kang U.G., Kim Y.-S., and Juhnn Y.-S. Membrane depolarization induces the undulating phosphorylation/dephosphorylation of glycogen synthase kinase 3β, and this dephosphorylation involves protein phosphatases 2A and 2B in SH-SY5Y human neuroblastoma cells. J. Biol. Chem. 280 (2005) 22044-22052
27. Meijer L., Flajolet M., and Greengard P. Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol. Sci. 25 (2004) 471-480
28. Pardo R., Andreolotti A.G., Ramos B., Picatoste F., and Claro E. Opposed effects of lithium on the MEK-ERK pathway in neural cells: inhibition in astrocytes and stimulation in neurons by GSK3 independent mechanisms. J. Neurochem. 87 (2003) 417-426
29. Pederson T.M., Kramer D.L., and Rondinone C.M. Serine/threonine phosphorylation of IRS-1 triggers its degradation. Possible regulation by tyrosine phosphorylation. Diabetes 50 (2001) 24-31
30. Roh M.-S., Kang U.G., Shin S.Y., Lee Y.H., Jung H.Y., Juhnn Y.-S., and Kim Y.S. Biphasic changes in the Ser-9 phosphorylation of glycogen synthase kinase-3β after electroconvulsive shock in the rat brain. Prog. Neuro-psychopharmacol. Biol. Psychiatry 27 (2003) 1-5
31. Rui L., Fisher T.L., Thomas J., and White M.F. Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2. J. Biol. Chem. 276 (2001) 40362-40367
32. Sadagurski M., Weingarten G., Rhodes C.J., White M.F., and Wertheimer E. Insulin receptor substrate 2 plays diverse cell-specific roles in the regulation of glucose transport. J. Biol. Chem. 280 (2005) 14536-14544
33. Saitoh T., Yanagita T., Shiraishi S., Yokoo H., Kobayashi H., Minami S., Onitsuka T., and Wada A. Down-regulation of cell surface insulin receptor and insulin receptor substrate-1 phosphorylation by inhibitor of 90-kDa heat-shock protein family: endoplasmic reticulum retention of monomeric insulin receptor precursor with calnexin in adrenal chromaffin cells. Mol. Pharmacol. 62 (2002) 847-855
34. Schmidt R.E., Dorsey D.A., Beaudet L.N., Plurad S.B., Parvin C.A., and Miller M.S. Insulin-like growth factor I reverses experimental diabetic autonomic neuropathy. Am. J. Pathol. 155 (1999) 1651-1660
35. Schubert M., Brazil D.P., Burks D.J., Kushner J.A., Ye J., Flint C.L., Farhang-Fallah J., Dikkes P., Warot X.M., Rio C., Corfas G., and White M.F. Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation. J. Neurosci. 23 (2003) 7084-7092
36. Sesti G., Federici M., Hribal M.L., Lauro D., Sbraccia P., and Lauro R. Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB J. 15 (2001) 2099-2111
37. Shimoaka T., Kamekura S., Chikuda H., Hoshi K., Chung U., Akune T., Maruyama Z., Komori T., Matsumoto M., Ogawa W., Terauchi Y., Kadowaki T., Nakamura K., and Kawaguchi H. Impairment of bone healing by insulin receptor substrate-1 deficiency. J. Biol. Chem. 279 (2004) 15314-15322
38. Shiraishi S., Yokoo H., Kobayashi H., Yanagita T., Uezono Y., Minami S., Takasaki M., and Wada A. Post-translational reduction of cell surface expression of insulin receptors by cyclosporin A, FK506 and rapamycin in bovine adrenal chromaffin cells. Neurosci. Lett. 293 (2000) 211-215
39. 2+ATPase inhibitor in adrenal chromaffin cells. Brain Res. 898 (2001) 152-157
40. Sproule B. Lithium in bipolar disorder: can drug concentrations predict therapeutic effect?. Clin. Pharmacokinet. 41 (2002) 639-660
41. Sugano T., Yanagita T., Yokoo H., Satoh S., Kobayashi H., and Wada A. Enhancement of insulin-induced PI3K/Akt/GSK-3β and ERK signalings by neuronal nicotinic receptor/PKC-α/ERK pathway: up-regulation of IRS-1/-2 mRNA and protein in adrenal chromaffin cells. J. Neurochem. 98 (2006) 20-33
42. Sun H., Tu X., Prisco M., Wu A., Casiburi I., and Baserga R. Insulin-like growth factor I receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2. Mol. Endocrinol. 17 (2003) 472-486
43. Takada Y., Fang X., Jamaluddin M.S., Boyd D.D., and Aggarwal B.B. Genetic deletion of glycogen synthase kinase-3β abrogates activation of IκBα kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor. J. Biol. Chem. 279 (2004) 39541-39554
44. Taniguchi C.M., Ueki K., and Kahn C.R. Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J. Clin. Invest. 115 (2005) 718-727
45. Trejo J.L., Carro E., Lopez-Lopez C., and Torres-Aleman I. Role of serum insulin-like growth factor I in mammalian brain aging. Growth Horm. IGF Res. 14 (2004) S39-S43
46. Tseng Y.-H., Ueki K., Kriauciunas K.M., and Kahn C.R. Differential roles of insulin receptor substrates in the anti-apoptotic function of insulin-like growth factor-1 and insulin. J. Biol. Chem. 277 (2002) 31601-31611
47. Tyson D.R., Swarthout J.T., Jefcoat S.C., and Partridge N.C. PTH induction of transcriptional activity of the cAMP response element-binding protein requires the serine 129 site and glycogen synthase kinase-3 activity, but not casein kinase II sites. Endocrinology 143 (2002) 674-682
48. Wada A., Yokoo H., Yanagita T., and Kobayashi H. New twist on neuronal insulin receptor signaling in health, disease, and therapeutics. J. Pharmacol. Sci. 99 (2005) 128-143
49. Wada A., Yokoo H., Yanagita T., and Kobayashi H. Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases. J. Pharmacol. Sci. 99 (2005) 307-321
50. Yamamoto R., Yanagita T., Kobayashi H., Yuhi T., Yokoo H., and Wada A. Up-regulation of functional voltage-dependent sodium channels by insulin in cultured bovine adrenal chromaffin cells. J. Neurochem. 67 (1996) 1401-1408
51. Yamamoto R., Kobayashi H., Yanagita T., Yokoo H., Kurose T., Shiraishi S., Minami S., Matsukura S., and Wada A. Up-regulation of cell surface insulin receptor by protein kinase C-α in adrenal chromaffin cells: involvement of transcriptional and translational events. J. Neurochem. 75 (2000) 672-682
52. Yokoo H., Saitoh T., Shiraishi S., Yanagita T., Sugano T., Minami S., Kobayashi H., and Wada A. Distinct effects of ketone bodies on down-regulation of cell surface insulin receptor and insulin receptor substrate-1 phosphorylation in adrenal chromaffin cells. J. Pharmacol. Exp. Ther. 304 (2003) 994-1002
53. Zhao W.-Q., and Alkon D.L. Role of insulin and insulin receptor in learning and memory. Mol. Cell. Endocrinol. 177 (2001) 125-134
54. Zhao W.-Q., Chen H., Quon M.J., and Alkon D.L. Insulin and the insulin receptor in experimental models of learning and memory. Eur. J. Pharmacol. 490 (2004) 71-81
55. Zick Y. Insulin resistance: a phosphorylation-based uncoupling of insulin signaling. Trends Cell Biol. 11 (2001) 437-441